(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIPIVIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LIPIVIR

ST13

US500000090210400

Class

3, 5, 44

Filing

90210400

Registration

7674548

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

02/04/2025

Trademark type

Word

Nice classes

3, 5, 44

Filing date

09/25/2020

Registration date

02/04/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/04/2025

Last transaction

02/04/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Rotkreuz, CH

Examiner

O'ROURKE, JONATHAN RYAN

Law office

L40

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Devirex AG

Representatives

Scott M. Sisun, Esq. SISUN LAW

Technical classification

Nice Classes

Class 3Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Body and beauty care productscosmetics

Class 5

Antiviral dermatological products for external usecold sore treatment and prevention preparations

Class 44

Hygienic and beauty care for humans and animals

Publications

History of USPTO decisions and trademark events.

39 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/17/2024

PUBO

PUBLISHED FOR OPPOSITION

12/17/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

11/21/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/12/2024

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

10/17/2024

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

10/17/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/25/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/25/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/25/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/23/2024

GNFR

FINAL REFUSAL E-MAILED

07/23/2024

CNFR

FINAL REFUSAL WRITTEN

07/23/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/10/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/14/2024

GNRT

NON-FINAL ACTION E-MAILED

03/14/2024

CNRT

NON-FINAL ACTION WRITTEN

03/14/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

03/14/2024

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

03/08/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

09/10/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/09/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

09/09/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/09/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

09/09/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/02/2021

ALIE

ASSIGNED TO LIE

08/02/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/29/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/23/2021

GNRT

NON-FINAL ACTION E-MAILED

02/23/2021

CNRT

NON-FINAL ACTION WRITTEN

02/23/2021

DOCK

ASSIGNED TO EXAMINER

02/16/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/05/2020

NWAP

NEW APPLICATION ENTERED

09/29/2020

Continuous trademark protection

Get notified about every new filing that threatens LIPIVIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.